In a clinical study, it was found that the Nanox.ARC digital tomosynthesis enhanced musculoskeletal imaging, can improve the sensitivity and ...

CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in ...

Nano-X Imaging shares were up 10%, to $6.61, after the company said it has received CE mark certification to market its multi-source Nanox.ARC system, including the Nanox.CLOUD, its accompanying cloud ...

Nanox Imaging Ltd. announced promising results from a clinical study showcasing its Nanox.ARC digital tomosynthesis system, which enhances musculoskeletal imaging and outperforms conventional ...

Its main product is Nanox.ARC, which is designed to make CT scanning much more affordable and accessible than products using the conventional approach. The company believes that its system is more ...

PETACH TIKVA, Israel, Feb. 25, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that ...

Nano-X Imaging (NASDAQ:NNOX) received CE mark certification to market the Nanox.ARC system, including the Nanox.CLOUD, its accompanying cloud-based infrastructure.  The company said new clinical data ...

In a clinical study, it was found that the Nanox.ARC digital tomosynthesis enhanced musculoskeletal imaging, can improve the sensitivity and specificity of conventional radiography. In addition ...

CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in the U.S. New clinical data supporting use of Nanox ...